Lally, Lindsay
Spiera, Robert
Article History
First Online: 8 January 2024
Competing interests
: L.L. has received consulting fees from Amgen/ChemoCentryx. R.S. has received grants and/or research support from, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, ChemoCentryx, Corbus, Cytori, Formation Biologics, GSK, Novartis and Roche-Genentech, and consulting fees from Abbvie, AstraZeneca, ChemoCentryx, Cytori, Galderma, GSK, Janssen, Novartis, Ortho Dermatologics, Roche-Genentech and Sanofi.